Korean J Reprod Med.  2009 Sep;36(3):225-230.

A Case of Malignant Melanoma During Hormone Therapy

Affiliations
  • 1Department of Obstetrics and Gynecology, College of Medicine, Medical Research Center, Seoul National University, Seoul, Korea. jyhsyk@snu.ac.kr
  • 2Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University, Seoul, Korea.

Abstract

Over the last several decades, the incidence of malignant melanoma has been increasing rapidly. The annual incidence rates have increased approximately 3~7% in Caucasian population. The rate of increase is highest in perimenopausal period in women. The relationship between risk of melanoma and female hormone is still unclear. The safety of hormone therapy for the melanoma patients is not known. We experienced a case of melanoma in whom underwent hormone therapy for 10 years. We report this case with a brief review of literature.

Keyword

Malignant melanoma; Hormone therapy; Estrogen; Menopause

MeSH Terms

Estrogens
Female
Humans
Incidence
Melanoma
Menopause
Estrogens
Full Text Links
  • KJRM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr